| Title | Author(s) | Year | View Count |
 | Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion | Ng, L; Poon, RTP; Yau, WL; Chow, KM; Lam, SC; Li, HS; Yau, TCC; Law, WL; Pang, RWC | 2013 | 18 |
 | Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process | Yau, WL; Lam, SC; Ng, L; Chow, KM; Chan, TC; Chan, JYK; Wo, YH; Ng, KTP; Man, K; Poon, RTP; Pang, RWC | 2013 | 8 |
| Enhanced therapeutic efficacy of transarterial chemoembolisation treatment in hepatocelluar carcinoma (HCC) by mTOR inhibitor RAD001: implication for a novel treatment regimen in HCC | Chu, ACY; Poon, RTP; Lam, SC; Chow, KM; Pang, R | 2011 | 149 |
| XIAP-associated factor 1 (XAF1), a novel target gene of p53, enhances p53-mediated apoptosis via a post-translational modification mechanism 'Manuscript in submission' | Zou, B; Chim, JCS; Pang, RWC; Zeng, H; Dai, Y; Zhang, R; Lam, SC; Tan, VPY; Hung, IFN; Wang, J; Lan, HY; Wong, BCY | 2009 | 195 |
|
